Cervical Cancer Clinical Trial
Official title:
The Organ Transplant Recipient HPV and Skin Cancer Study
Solid organ transplant recipients (OTRs) receive lifelong immunosuppressive therapy, which puts them at increased risk of cutaneous and mucosal cancers. In particular, OTRs have increased risk of skin cancer and cancers caused by human papillomavirus (HPV), including cervical cancer and oropharyngeal cancer. There is currently limited knowledge on risk factors for HPV infection and skin cancer in OTRs, and limited knowledge on the natural history of HPV infection and cervical neoplasia in OTRs compared with immunocompetent controls. With a continuously increasing number of OTRs, there is a growing need to improve our understanding of the long-term reactions to immunosuppression. The overall aim of this study is to investigate long term effects of immunosuppression on cutaneous and mucosal epithelium in Danish OTRs, including the risk of skin dysplasia and skin cancer, cervical and oral HPV infection and HPV-related dysplasia and cancer in OTRs. This study will be designed as a prospective observational cohort study based on clinical data and data from nationwide Danish registries. A total of 600 female OTRs, 600 male OTRs and 600 female controls will be included from Danish dermatology departments. The study aims to provide knowledge relevant for improving prevention of skin- and HPV-related cancers in OTRs, including personalized screening recommendations according to individual patient risk.
Status | Recruiting |
Enrollment | 1800 |
Est. completion date | April 2027 |
Est. primary completion date | April 2027 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria for OTRs: - Patients aged =18 years - Solid organ transplantation recipients, i.e. kidney-, liver-, lung-, and heart transplant recipients - Stable immunosuppressive treatment for =3 months - No signs of acute graft rejection - Patients who reside in Denmark - Informed written consent obtained Exclusion Criteria for OTRs: - Patients with concomitant bone marrow transplantation - Full hysterectomy Inclusion Criteria for Control group: - Able patients aged =18 years - No known immunosuppressive therapy or -condition - Patients who reside in Denmark - Informed written consent obtained Exclusion Criteria for Control group: - Full hysterectomy |
Country | Name | City | State |
---|---|---|---|
Denmark | Department of Dermatology, Bispebjerg Hospital | Copenhagen NV | Region Hovedstaden |
Denmark | Department of Dermatology and Allergy, Herlev og Gentofte Hospital | Hellerup | Region Hovedstaden |
Denmark | Department of Dermatology, Zealand University Hospital | Roskilde | Region Sjælland |
Lead Sponsor | Collaborator |
---|---|
Merete Haedersdal | Danish Cancer Society, Herlev and Gentofte Hospital, Rigshospitalet, Denmark, Vejle Hospital, Zealand University Hospital |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Difference in prevalence, incidence and persistence of cervical HPV infection in female OTRs compared to immunocompetent controls. | Number of women with cervical HPV infection measured by PCR test. | Evaluated at baseline and month 12 | |
Secondary | Difference in prevalence of oral HPV infection in female OTRs compared to immunocompetent controls. | Number of women with oral HPV infection measured by PCR test. | Evaluated at baseline | |
Secondary | Correlations between lifestyle factors, clinical factors and occurrence of cervical HPV infection in female OTRs. | Lifestyle factors determined by questionnaire. Clinical factors from medical records. Number of women with cervical HPV infection measured by PCR test. | Evaluated at baseline | |
Secondary | Correlations between lifestyle factors, clinical factors and occurrence of oral HPV infection in female OTRs. | Lifestyle factors determined by questionnaire. Clinical factors from medical records. Number of women with oral HPV infection measured by PCR test. | Evaluated at baseline | |
Secondary | Difference in prevalence and incidence of HPV-related dysplasia and cancer in female OTRs compared to immunocompetent controls. | Number of women with HPV-related dysplasia and HPV-related cancer from registries using registry linkage. | Evaluated at baseline and during up to 15 years after baseline. | |
Secondary | Correlations between lifestyle factors, clinical factors and prevalence of skin dysplasia and cancer in OTRs. | Lifestyle factors determined by a questionnaire. Clinical factors from medical records. Skin dysplasia and skin cancer assessed by clinical evaluation and by non-invasive imaging. | Evaluated at baseline | |
Secondary | Correlation between Vitamin D and prevalence of skin dysplasia and cancer in OTRs. | Vitamin D from blood sample analysis. Skin dysplasia and skin cancer assessed by clinical evaluation and non-invasive imaging. | Evaluated at baseline | |
Secondary | Correlations between skin pigmentation, facial solar lentigines and prevalence of skin dysplasia and cancer in OTRs. | Skin pigmentation measured with skin reflectance. Facial solar lentigines measured by photographs. Skin dysplasia and skin cancer assessed by clinical evaluation and non-invasive imaging. | Evaluated at baseline | |
Secondary | Correlation between prevalence of cervical HPV infection and prevalence of skin dysplasia and cancer in OTRs. | Number of women with cervical HPV infection measured by PCR test. Skin dysplasia and skin cancer assessed by clinical evaluation and non-invasive imaging. | Evaluated at baseline | |
Secondary | Correlations between history of herpes zoster, prevalence of cervical HPV infection and prevalence of skin dysplasia and cancer in OTRs. | Number of women with history of herpes zoster determined by questionnaire. Number of women with cervical HPV infection measured by PCR test. Skin dysplasia and skin cancer assessed by clinical evaluation and non-invasive imaging. | Evaluated at baseline | |
Secondary | Difference in prevalence and incidence of skin cancer in female OTRs compared to immunocompetent controls. | Number of women with skin cancer from registries using registry linkage | Evaluated at baseline and during up to 15 years after baseline. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06223308 -
A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Terminated |
NCT03367871 -
Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer
|
Phase 2 | |
Active, not recruiting |
NCT04537156 -
Efficacy, Immunogenicity and Safty Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
|
Phase 3 | |
Recruiting |
NCT03668639 -
Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT04242199 -
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
|
Phase 1 | |
Withdrawn |
NCT04806945 -
A Phase III Study to Evaluate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy in Patients With Advanced Cervical Cancer
|
Phase 3 | |
Active, not recruiting |
NCT04185389 -
Long-Term Follow-Up of HPV FOCAL Participants
|
||
Withdrawn |
NCT03007771 -
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
|
Phase 1 | |
Completed |
NCT03384511 -
The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.
|
Phase 4 | |
Recruiting |
NCT05107674 -
A Study of NX-1607 in Adults With Advanced Malignancies
|
Phase 1 | |
Completed |
NCT05120167 -
Strategies for Endocervical Canal Investigation in Women With Abnormal Screening Cytology and Negative Colposcopy
|
N/A | |
Recruiting |
NCT05483491 -
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
|
Phase 1 | |
Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
Completed |
NCT05862844 -
Promise Women Project
|
N/A | |
Recruiting |
NCT04934982 -
Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IA1 With LVSI, IA2)
|
N/A | |
Recruiting |
NCT03876860 -
An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis
|
N/A | |
Completed |
NCT03652077 -
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
|
Phase 1 | |
Completed |
NCT00543543 -
Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)
|
Phase 3 | |
Terminated |
NCT04864782 -
QL1604 Plus Chemotherapy in Subjects With Stage IVB, Recurrent, or Metastatic Cervical Cancer
|
Phase 2/Phase 3 | |
Recruiting |
NCT04226313 -
Self-sampling for Non-attenders to Cervical Cancer Screening
|
N/A |